Biotech / MedTech
Singapore BioTech TurtleTree raises $30M Series A funding led by European investor VERSO Capital
Turtle Tree has successfully raised $30 million in the first tranche of its Series A funding, one of the largest investment rounds to date in Asia's cell-based food sector. The funding sees participation from investors worldwide, including lead investor VERSO Capital. Following this round of funding, TurtleTree has now raised over US$40 million to date.
MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline
Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.
Insilico Medicine closes $255M Series C led by Warburg Pincus to further develop AI and drug discovery
Proceeds from the funding will be used to progress Insilico Medicine's current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities, the company added.
Bot MD secures $5M Series A amid pandemic-driven demand for MedTech
Fresh capital will be used to expand in other Asia-Pacific countries such as Indonesia, Malaysia, India, and the Philippines and improve the platform to include new features based on accelerated demand driven by the pandemic.
Daiwa VC fund manager DCI Partners launches $135M fund to accelerate drug discovery
Tokyo-based DCI Partners, a venture fund manager of Daiwa Securities Group, has announced the launch of Daiwa Taiwan-Japan BioVenture Investment Limited Partnership II, a $135 million (JPY 14 billion) investment fund intended for drug discovery.
In Singapore, AI helps cancer patients find clinical trials
Next, the startup is expanding across Southeast Asia.
Alternative meat startups are making slow progress across Southeast Asia
By the end of this year, shoppers in Southeast Asia will finally get some plant-based pork.
